- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
December 16th, 2009
"Some of the most essential questions in nanomedicine today are about biodistribution--where particles go inside the body and how they get there," says Naomi Halas, a nanomedicine pioneer at Rice University in Houstin, Texas, whose findings have just been published in Advanced Functional Materials. "Noninvasive tests for biodistribution will be enormously useful on the path to FDA approval, and this technique--adding MRI functionality to the particle you're testing and using for therapy--is a very promising way of doing this."
The all-in-one particles are modeled on nanoshells, a cancer treatment Halas invented in the '90s that are now in human clinical trials. The shells harvest laser light that would typically pass through the body harmlessly and convert that light into heat that destroys cancerous cells.
|Related News Press|
News and information
Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015
Healthcare Nanotechnology (Nanomedicine) Market Size To 2020 June 5th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015